Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.
We have evaluated the ability of two carbohydrate biopolymers, chitosan and gellan, to enhance antibody responses to subunit influenza virus vaccines delivered to the respiratory tracts of mice. Groups of mice were vaccinated three times intranasally (i.n.) with 10 microg of purified influenza B/Panama virus surface antigens (PSAs), which consist of hemagglutinin (HA) and neuraminidase (NA), either alone or admixed with chitosan or gellan solutions. Separate groups were vaccinated subcutaneously (s.c.) with PSAs adsorbed to Alhydrogel or chitosan or gellan alone i.n. Serum antibody responses were determined by enzyme-linked immunosorbent assay (ELISA) for influenza virus-specific immunoglobulin G (IgG) and by HA inhibition (HAI) and NA inhibition (NAI) assays. The local respiratory immune response was measured by assaying for influenza virus-specific IgA antibody in nasal secretions and by enumerating nasal and pulmonary lymphocytes secreting IgA, IgG, and IgM anti-influenza virus-specific antibodies by enzyme-linked immunospotting (ELISPOT). When administered alone i.n., B/Panama PSA was poorly immunogenic. Parenteral immunization with B/Panama PSA with Alhydrogel elicited high titers of anti-B/Panama antibodies in serum but a very poor respiratory anti-B/Panama IgA response. In contrast, i.n. immunization with PSA plus chitosan stimulated very strong local and systemic anti-B/Panama responses. Gellan also enhanced the local and serum antibody responses to i.n. PSA but not to the same extent as chitosan. The ability of chitosan to augment the immunogenicity of influenza vaccines given i.n. was confirmed using PSA prepared from an influenza A virus (A/Texas H1N1).
Bacon
A
A
Vaccine Research Unit (Medeva Group Development), Department of Biochemistry, Imperial College of Science and Technology, London SW7 2AY, United Kingdom.
Makin
J
J
Sizer
P J
PJ
Jabbal-Gill
I
I
Hinchcliffe
M
M
Illum
L
L
Chatfield
S
S
Roberts
M
M
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D000954:Antigens, Surface / Q000276:immunology; D001704:Biopolymers / Q000737:chemistry / Q000276:immunology; D002686:Chitin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000276:immunology; D048271:Chitosan; D005260:Female; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009439:Neuraminidase / Q000008:administration & dosage / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology*; D012137:Respiratory System / Q000276:immunology; D014611:Vaccination
D000914:Antibodies, Viral; D000954:Antigens, Surface; D001704:Biopolymers; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D007071:Immunoglobulin A, Secretory; D007252:Influenza Vaccines; D011135:Polysaccharides, Bacterial; D002686:Chitin; C048288:gellan gum; D048271:Chitosan; D009439:Neuraminidase